• For the three months ended June 30, 2026, revenue slipped to $503,156 from $505,796, reflecting lower consumables partly offset by higher service.
• Six-month revenue fell to $887,760 from $1.06 million, driven mainly by an equipment sale recorded in the prior-year period.
• Net loss narrowed to $2.54 million from $3.88 million, as operating expenses declined on lower personnel costs.
• R&D spending dropped to $819,891 from $1.51 million, reflecting completion of Claire-related clinical and regulatory work in 2025.
• Cash rose to $6.44 million at June 30, 2026 from $2.47 million, supported by warrant exercises, the LIFE offering, and convertible debentures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perimeter Medical Imaging AI Inc. published the original content used to generate this news brief on August 26, 2026, and is solely responsible for the information contained therein.